SARS-CoV-2-Impfstoffkandidat : US-Firma Moderna publiziert ermutigende Daten
Pharmazeutische Zeitung,
Moderna war einer der ersten Hersteller, der mit der klinischen Entwicklungsphase seines Impfstoffkandidaten mRNA-1273 begonnen…
Moderna war einer der ersten Hersteller, der mit der klinischen Entwicklungsphase seines Impfstoffkandidaten mRNA-1273 begonnen…
Исследование первой вакцины против COVID-19 демонстрирует обещающие результаты Способна ли она предупреждать болезнь, покажет исп…
No study volunteers experienced a serious side effect. Moderna Inc’s (MRNA.O) experimental vaccine for COVID-19 showed it was…
An experimental coronavirus vaccine made by the biotech company Moderna provoked a promising immune response against the virus…
After promising results from a Phase 2 clinical trial, Moderna is now planning to recruit 30,000 people for the next stage of…
Im Rennen um einen Corona-Impfstoff sind die USA einen Schritt vorangekommen. Ein experimentelles Mittel der US-Biotech-Firma…
В США прошли успешные испытания вакцины от коронавирусной инфекции на людях. По итогам первой фазы тестов иммунитет к вирусу выро…
В проведённом в Сиэтле (штат Вашингтон) и Атланте (штат Джорджия) исследовании приняли участие 45 здоровых добровольцев в возраст…
mRNA-1273, an experimental COVID-19 vaccine, was generally well tolerated and prompted neutralising antibody activity in…
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (CO…
As different companies and nations around the world rush to discover a vaccine against SARS-CoV-2, some are starting to show…
Moderna's coronavirus vaccine appears safe and stimulates the production of key antibodies that might prevent COVID-19…
Вакцина для профилактики нового коронавируса, созданная американской компанией Moderna, вызвала сильный иммунный ответ у всех исп…
Advertisement An experimental COVID-19 vaccine developed by Moderna Therapeutics, a US biotech firm, has generated a positive…
Moderna Inc’s experimental vaccine for Covid-19 showed it was safe and provoked immune responses in all 45 healthy volunteers…
Share Facebook Twitter Google + LinkedIn Pinterest Within 12 hours of receiving the second dose of an experimental COVID-19…
Source link No study volunteers experienced a serious side effect, but more than half reported mild or moderate reactions.
Det amerikanska bioteknikbolaget Moderna uppger att man är redo att gå in i nästa fas för att få fram ett vaccin mot covid-19.
Moderna Inc’s experimental vaccine for Covid-19 showed it was safe and provoked immune responses in all 45 healthy volunteers…
Colorized scanning electron micrograph of an apoptotic cell (green) heavily infected with SARS-COV-2 virus particles (purple)…
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (CO…
Экспериментальная вакцина против коронавируса, созданная американской компанией Moderna, смогла вызвать иммунный ответ у всех доб…
Det amerikanska bioteknikbolaget Moderna uppger att man är redo att gå in i nästa fas för att få fram ett vaccin mot covid-19.
Washington, Xinhua/UNB, July 15 – An experimental COVID-19 vaccine – mRNA-1273 – was generally well tolerated and prompted…
A vacina da Moderna deu origem a defesas contra a covid-19 em 45 voluntários saudáveis.
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes coronavirus disease 2019 (CO…
Итоги первой фазы клинических испытаний на людях вакцины от коронавирусной инфекции, разрабатываемой американской компанией…
Moderna Inc's experimental vaccine seems to have crossed an important milestone as the world continues to grapple with a surge…
À partir du 27 juillet et jusqu’au 27 octobre 2022, 30 000 personnes participeront à la dernière phase de l’essai clinique du…
WASHINGTON, July 14 (Xinhua) -- An investigational COVID-19 vaccine, mRNA-1273, was generally well tolerated and prompted…
Экспериментальная вакцина против COVID-19, которую разрабатывает американская компания Moderna, показала сильный иммунный ответ н…
Moderna Inc’s experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers…
An experimental coronavirus vaccine made by the biotech company Moderna provoked a promising immune response against the virus…
Het Amerikaanse biotechbedrijf Moderna start op 27 juli als eerste bedrijf de finale fase van de klinische tests voor de…
Die Impfungen der Biotech-Firma Moderna zeigten bei allen Testpersonen eine Wirkung.
Moderna Inc’s experimental vaccine for Covid-19 showed it was safe and provoked immune responses in all 45 healthy volunteers…
現地時間2020年7月14日、アメリカのバイオテクノロジー企業の Moderna が、 アメリカ国立衛生研究所 と共同で開発を進めてきた新型コロナウイルスワクチン「 mRNA-1273 」の第一相試験に参加した被験者全員が免疫反応を獲得したと発表しました。新…
Within 12 hours of getting the second dose of being developed by Moderna Inc., Ian Haydon began to feel chills.
Within 12 hours of getting the second dose of an experimental COVID-19 vaccine being developed by Moderna Inc., Ian Haydon…
Massachusetts-based biotech firm Moderna Inc. on Tuesday announced mRNA-1273, its candidate vaccine against COVID-19, had…
Jeff Sessions loses Alabama GOP Senate runoff to Tommy Tuberville Trump's niece says the way he was raised left him 'utterly…
In a study published July 14 in the New England Journal of Medicine, researchers report on the results of the first COVID-19…
Washington. Die US-Biotechfirma Moderna ist zuversichtlich: Trotz Nebenwirkungen will sie klinische Tests für einen möglichen…
Actualisé il y a 9min Coronavirus Le virus continue sa trajectoire inquiétante et plusieurs pays procèdent à un retour aux…
Le virus continue sa trajectoire inquiétante et plusieurs pays procèdent à un retour aux restrictions.
Special: Battle Against Novel Coronavirus An investigational COVID-19 vaccine, mRNA-1273, was generally well tolerated and…
WASHINGTON, July 14 (Xinhua) -- An investigational COVID-19 vaccine, mRNA-1273, was generally well tolerated and prompted…
Moderna was the first to start human testing of a vaccine for the novel coronavirus on March 16, 66 days after the genetic…
La cadena de noticias CNBC informó que “los futuros de las acciones subieron más en las operaciones de la noche a la mañana del…
Après la publication de résultats préliminaires prometteurs, le laboratoire américain Moderna a annoncé mardi le lancement…
In a study published July 14 in the New England Journal of Medicine, researchers report on the results of the first COVID-19…
KEY POINTS A published and peer-reviewed study reveald the anti-COVID-19 vaccine mRNA-1273 generated an immune response in all…
A corrida por uma vacina funcional contra a Covid-19 ganhou um novo competidor forte nesta terça-feira (14).
The US biotech firm Moderna said Tuesday it would enter the final stage of human trials for its COVID-19 vaccine on July 27…
Det amerikanska bioteknikbolaget Moderna uppger att man är redo att gå in i nästa fas för att få fram ett vaccin mot covid-19.
Après la publication de résultats préliminaires prometteurs, le laboratoire américain Moderna a annoncé mardi le lancement…
CDC Director: Coronavirus could be 'under control' in 2 months if Americans wore masks Ruth Bader Ginsburg hospitalized with…
I n a study published July 14 in the New England Journal of Medicine, researchers report on the results of the first COVID-19…
In a, researchers report on the results of the first COVID-19 vaccine to be tested in people.
CHICAGO (Reuters) – Moderna Inc’s experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45…
Moderna, la compañía de biotecnología estadounidense, informó este martes 14 de julio que su vacuna contra el covid-19 entrará…
Bradley Peniston Deputy Editor Read bio 10:37 AM ET Topics AA Font size + Print By Ben Watson News Editor Read bio Bradley…
杂志》(NEJM)公布了Moderna疫苗的最新数据。在早期人体试验中,其新冠候选疫苗(mRNA-1273)在所有45名受试者身上都产生了“强有力”的免疫反应。消息传出后,Moderna股价盘后一度大涨17%。该公司周二收涨4.54%,报75.04美元。 这…
A COVID-19 vaccine candidate developed by the biotechnology company Moderna is expected to begin a large Phase 3 trial – the…
TOPLINE The market opened sharply higher on Wednesday as stocks got a boost from positive coronavirus vaccine news and blowout…
La vacuna experimental de Moderna para Covid-19 demostró que era segura y provocó respuestas inmunes en los 45 voluntarios…
An investigational vaccine, mRNA-1273, designed to protect against SARS-CoV-2, the virus that causes COVID-19, was generally…
Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus…
Editor’s note: The Salt Lake Tribune is providing free access to critical stories about the coronavirus.
https://ria.ru/20200715/1574362133.html Вакцина для профилактики COVID-19, разработанная американской компаний Moderna, вызвала с…
Moderna stock surged more than 14 percent in after-hours trading following positive results from the company's "Phase 1" study…
Una vacuna en investigación contra el virus SARS-COV-2 fue bien tolerada y generó una actividad de anticuerpos neutralizantes…
Infectious Disease > COVID-19 But questions about dosing remain Moderna's mRNA vaccine against SARS-CoV-2 produced an immune…
The first vaccine against COVID-19 tested in the United States is moving into its final phase with promising results, according…
La primera vacuna contra covid-19, probada en 45 adultos sanos, de 18 a 55 años, en Estados Unidos, estimuló el sistema inmunológ…
Former Health and Human Services Secretary Tom Price shares insights into the development of a coronavirus vaccine and what…
Click to expand CAMBRIDGE, Mass. – A candidate vaccine against COVID-19 developed by the federal government and Moderna, Inc.…
CDC Director: Coronavirus could be 'under control' in 2 months if Americans wore masks Researchers got the immune-boosting…
Highlights With mRNA, scientists hope to develop a vaccine that produces desired levels of immunity Due to its inherent nature…
CAMBRIDGE, Mass. – A candidate vaccine against COVID-19 developed by the federal government and Moderna, Inc., appears to be…
Estimuló el sistema inmunológico de la personas que la recibieron. Una luz de esperanza 45 voluntarios desarrollaron…
CAMBRIDGE, Mass. – A candidate vaccine against COVID-19 developed by the federal government and Moderna, Inc., appears to be…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
One of the leading COVID-19 vaccine candidates produced virus antibodies in every patient tested in a trial conducted earlier…
A coronavirus vaccine by Cambridge-based biotechnology company Moderna triggers an immune response, according to data published…
Healthy volunteers who took Moderna's coronavirus vaccine candidate appeared to generate an immune system response to the virus…
Source: US Department of Health and Human Services – 2 News Release Tuesday, July 14, 2020 NIH-sponsored Phase 1 trial tested…
CAMBRIDGE, Mass. – A candidate vaccine against COVID-19 developed by the federal government and Moderna, Inc., appears to be…